BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Singapore scientists awarded Wellcome Leap R3 contract to develop mRNA technology

A team of researchers from A*STAR’s Genome Institute of Singapore (GIS) and Institute of Bioengineering and Bioimaging (IBB), together with the Natio...

January 07, 2022 | News

Aurobindo rolls out molnaflu, oral covid drug for adult patients In India

Molnupiravir was earlier approved under Emergency Use Authorisation from CDSCO, India. This is the first oral antiviral approved by India, the UK agency an...

January 06, 2022 | News

B. subtilis Spores, Biotechnology Breakthrough by DreamTec

Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) ha...

January 05, 2022 | News

Celltrion plans to provide dual treatment options for COVID-19 in South Korea

CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...

January 04, 2022 | News

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Covovax Receive EUA for COVID-19 Vaccine in India

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

December 29, 2021 | News

Japan Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection

Japan’s Ministry of Health, Labor and Welfare Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection Molnupiravir, First Oral COVID-19 Anti...

December 27, 2021 | News

WestVac BioPharma COVID-19 vaccine has achieved a significant progress against the Omicron

The vaccine belongs to the latest fifth generation vaccine technology, targeting the S-RBD protein of the COVID-19 mutant strain, the trimer subunit vaccin...

December 27, 2021 | News

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster

Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG...

December 23, 2021 | News

WHO SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine

SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emergency Use Li...

December 22, 2021 | News

EU Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows po...

December 21, 2021 | News

Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine

Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SPIKEVAX®. The brand nam...

December 20, 2021 | News

HKU microbiology researchers collaborating with vaccine manufacturers

After successfully isolating the SARS-CoV-2 Omicron variant from clinical specimens, researchers at the Department of Microbiology at The University of Hon...

December 14, 2021 | News

WHO Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the interim recommendation by the Strategic Advisory Group of Experts on Immunization ...

December 10, 2021 | News

Stay Connected